Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria

American Journal of Nephrology

Volumn 39, Issue 5, 2014, Pages 376-382

  Tang, Xiaojing ^a,c   Voskoboev, Nikolay V ^b   Wannarka, Stacie L ^b   Olson, Julie B ^a   Milliner, Dawn S ^a   Lieske, John C ^a,b  

^a MAYO CLINIC   (United States)

^b Laboratory Medicine and Pathology   (United States)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

End stage kidney disease; Hemodialysis; Oxalosis; Primary hyperoxaluria

Indexed keywords

OXALIC ACID; HEMODIALYSIS FLUID; OXALIC ACID DERIVATIVE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; DIALYSIS; FEMALE; HEMODIALYSATE; HUMAN; KIDNEY; KIDNEY CLEARANCE; LIMIT OF QUANTITATION; MALE; OXALOSIS 1; PRIORITY JOURNAL; URINE VOLUME; BLOOD LEVEL; DIALYSATE LEVEL; HEMODIALYSIS; HYPEROXALURIA; KIDNEY TRANSPLANTATION; METHODOLOGY; OXALOSIS; PLASMA; PRESCRIPTION; BLOOD; CHEMISTRY; HYPEROXALURIA, PRIMARY; ISOLATION AND PURIFICATION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PROCEDURES; RENAL REPLACEMENT THERAPY; TIME; URINE; VALIDATION STUDY; YOUNG ADULT;

ADULT; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; HYPEROXALURIA, PRIMARY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OXALATES; RENAL DIALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 84899591972     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000360624     Document Type: Article

References (23)

1. Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, Fargue S, Groothoff J, Harambat J, Hoppe B, Jamieson NV, Kemper MJ, Mandrile G, Marangella M, Picca S, Rumsby G, Salido E, Straub M, van Woerden CS: Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant 2012; 27: 1729-1736.
2. Hoppe B, Kemper MJ, Bokenkamp A, Portale AA, Cohn RA, Langman CB: Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Kidney Int 1999; 56: 268-274. (Pubitemid 29300544)
3. Ruder H, Otto G, Schutgens RB, Querfeld U, Wanders RJ, Herzog KH, Wolfel P, Pomer S, Scharer K, Rose GA: Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1. Eur J Pediatr 1990; 150: 56-58.
4. Canavese C, Petrarulo M, Massarenti P, Berutti S, Fenoglio R, Pauletto D, Lanfranco G, Bergamo D, Sandri L, Marangella M: Longterm, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis 2005; 45: 540-549. (Pubitemid 40341333)
5. Marangella M, Petrarulo M, Cosseddu D, Vitale C, Linari F: Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria. Am J Kidney Dis 1992; 19: 546-553.
6. Illies F, Bonzel KE, Wingen AM, Latta K, Hoyer PF: Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Kidney Int 2006; 70: 1642-1648. (Pubitemid 44607001)
7. Yamauchi T, Quillard M, Takahashi S, Nguyen-Khoa M: Oxalate removal by daily dialysis in a patient with primary hyperoxaluria type 1. Nephrol Dial Transplant 2001; 16: 2407-2411. (Pubitemid 33133855)
8. Watts RW, Veall N, Purkiss P: Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure. Clin Sci (Lond) 1984; 66: 591-597. (Pubitemid 14156955)
9. Kuhlmann U, Goldau R, Samadi N, Graf T, Gross M, Orlandini G, Lange H: Accuracy and safety of online clearance monitoring based on conductivity variation. Nephrol Dial Transplant 2001; 16: 1053-1058. (Pubitemid 32440382)
10. Hautmann R, Osswald H: Pharmacokinetic studies of oxalate in man. Invest Urol 1979; 16: 395-398. (Pubitemid 9186314)
11. Watts RW, Veall N, Purkiss P: Sequential studies of oxalate dynamics in primary hyperoxaluria. Clin Sci (Lond) 1983; 65: 627-633. (Pubitemid 13018311)
12. Edvardsson VO, Goldfarb DS, Lieske JC, Beara-Lasic L, Anglani F, Milliner DS, Palsson R: Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol 2013; 28: 1923-1942.
13. Ladwig PM, Liedtke RR, Larson TS, Lieske JC: Sensitive spectrophotometric assay for plasma oxalate. Clin Chem 2005; 51: 2377-2380. (Pubitemid 41692589)
14. Koch GH, Strong FM: Determination of oxalate in urine. Anal Biochem 1969; 27: 162-171.
15. Milliner DS, Wilson DM, Smith LH: Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. Kidney Int 2001; 59: 31-36. (Pubitemid 32055211)
16. Marangella M, Vitale C, Petrarulo M, Tricerri A, Cerelli E, Cadario A, Barbos MP, Linari F: Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure. Kidney Int 1995; 48: 182-187.
17. Harambat J, Fargue S, Acquaviva C, Gagnadoux MF, Janssen F, Liutkus A, Mourani C, Macher MA, Abramowicz D, Legendre C, Durrbach A, Tsimaratos M, Nivet H, Girardin E, Schott AM, Rolland MO, Cochat P: Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int 2010; 77: 443-449.
18. Bergstralh EJ, Monico CG, Lieske JC, Herges RM, Langman CB, Hoppe B, Milliner DS: Transplantation outcomes in primary hyperoxaluria. Am J Transplant 2010; 10: 2493-2501.
19. Marangella M, Petrarulo M, Mandolfo S, Vitale C, Cosseddu D, Linari F: Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis. Nephron 1992; 60: 74-80.
20. Monico CG, Rossetti S, Olson JB, Milliner DS: Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int 2005; 67: 1704-1709. (Pubitemid 40577704)
21. Monico CG, Milliner DS: Combined liverkidney and kidney-alone transplantation in primary hyperoxaluria. Liver Transpl 2001; 7: 954-963. (Pubitemid 33085784)
22. Goldstein SL, Silverstein DM, Leung JC, Feig DI, Soletsky B, Knight C, Warady BA: Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis. Pediatr Nephrol 2008; 23: 129-135. (Pubitemid 50001702)
23. Kraus M, Burkart J, Hegeman R, Solomon R, Coplon N, Moran J: A comparison of centerbased versus home-based daily hemodialysis for patients with end-stage renal disease. Hemodial Int 2007; 11: 468-477. (Pubitemid 47534874)